8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Mar 24, 2026·SEC
Material company update
Feb 26, 2026·SEC
Solventum Corporation(SOLV)Earnings, Financials & Key Ratios
SOLV•NYSE
$71.00
$12.32B mkt cap·8.0× P/E·Price updated May 6, 2026
AboutSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Show more
- Revenue$8.32B+0.9%
- EBITDA$2.67B+67.8%
- Net Income$1.56B+224.8%
- EPS (Diluted)8.88+221.7%
- Gross Margin53.47%-3.9%
- EBITDA Margin32.07%+66.4%
- Operating Margin26.2%+108.7%
- Net Margin18.69%+222.1%
- ROE38.86%+493.3%
- ROIC16.85%+225.1%
- Debt/Equity1.00-63.2%
- Interest Coverage5.94+124.1%
SOLV Key Insights
Solventum Corporation (SOLV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Good 3Y average ROE of 19.0%
- ✓Healthy 5Y average net margin of 15.1%
✗Weaknesses
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SOLV Price & Volume
Solventum Corporation (SOLV) stock price & volume — 10-year historical chart
Loading chart...
SOLV Growth Metrics
Solventum Corporation (SOLV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years0.79%
TTM-0.55%
Profit CAGR
10 Years-
5 Years-
3 Years5.03%
TTM277.84%
EPS CAGR
10 Years-
5 Years-
3 Years4.46%
TTM276.5%
Return on Capital
10 Years13.98%
5 Years13.98%
3 Years13.83%
Last Year19.04%
SOLV Recent Earnings
Solventum Corporation (SOLV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (100%)●Beat Revenue 9/12 qtrs (100%)
Q2 2026Latest
May 5, 2026EPS
$1.48
Est $1.35
+9.6%
Revenue
$2.0B
Est $2.0B
+2.0%
Q1 2026
Feb 26, 2026EPS
$1.57
Est $1.50
+4.7%
Revenue
$2.0B
Est $2.0B
+1.8%
Q4 2025
Nov 6, 2025EPS
$1.50
Est $1.43
+4.9%
Revenue
$2.1B
Est $2.1B
+2.0%
Q3 2025
Aug 7, 2025EPS
$1.69
Est $1.45
+16.6%
Revenue
$2.2B
Est $2.1B
+2.0%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $1.48vs $1.35+9.6% | $2.0Bvs $2.0B+2.0% |
| Q1 2026 | Feb 26, 2026 | $1.57vs $1.50+4.7% | $2.0Bvs $2.0B+1.8% |
| Q4 2025 | Nov 6, 2025 | $1.50vs $1.43+4.9% | $2.1Bvs $2.1B+2.0% |
| Q3 2025 | Aug 7, 2025 | $1.69vs $1.45+16.6% | $2.2Bvs $2.1B+2.0% |
Based on last 12 quarters of dataView full earnings history →
SOLV Peer Comparison
Solventum Corporation (SOLV) competitors in Healthcare staffing and facility services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BAX | 8.77B | 16.98 | -9.70 | 5.72% | -9.7% | -16.5% | 1.64 | |
 BDX | 52.45B | 144.76 | 24.83 | 8.23% | 8.01% | 6.93% | 0.76 | |
 COO | 11.97B | 61.12 | 32.68 | 5.06% | 9.67% | 4.83% | 0.34 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 10.37% | 0.52 | |
 ICU | 29.11M | 4.87 | -0.73 | -15.51% | -119.2% | |||
 HSIC | 8.31B | 72.44 | 22.15 | 4.03% | 3.02% | 8.24% | 0.77 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 ZBH | 16.22B | 82.83 | 23.33 | 7.2% | 9.05% | 5.77% | 0.59 |
Compare SOLV vs Peers
Solventum Corporation (SOLV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SOLV Income Statement
Solventum Corporation (SOLV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
| Sales/Revenue | 8.17B | 8.13B | 8.2B | 8.25B | 8.32B | 8.26B |
| Revenue Growth % | - | -0.5% | 0.82% | 0.7% | 0.86% | -0.55% |
| Cost of Goods Sold | 3.25B | 3.44B | 3.5B | 3.66B | 3.87B | 3.83B |
| COGS % of Revenue | 39.75% | 42.25% | 42.75% | 44.35% | 46.53% | - |
| Gross Profit | 4.92B▲ 0% | 4.7B▼ 4.6% | 4.69B▼ 0.0% | 4.59B▼ 2.1% | 4.45B▼ 3.1% | 4.43B▲ 0% |
| Gross Margin % | 60.25% | 57.75% | 57.25% | 55.65% | 53.47% | 53.67% |
| Gross Profit Growth % | - | -4.63% | -0.04% | -2.13% | -3.09% | - |
| Operating Expenses | 3.04B | 3B | 3B | 3.56B | 2.27B | 2.32B |
| OpEx % of Revenue | 37.25% | 36.93% | 36.61% | 43.09% | 27.27% | - |
| Selling, General & Admin | 2.28B | 2.23B | 2.24B | 2.78B | 3.08B | 3.14B |
| SG&A % of Revenue | 27.88% | 27.49% | 27.36% | 33.7% | 37% | - |
| Research & Development | 766M | 767M | 758M | 775M | 739M | 737M |
| R&D % of Revenue | 9.37% | 9.43% | 9.25% | 9.39% | 8.88% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1.55B | 0 |
| Operating Income | 1.88B▲ 0% | 1.69B▼ 9.9% | 1.69B▼ 0.1% | 1.04B▼ 38.8% | 2.18B▲ 110.5% | 2.11B▲ 0% |
| Operating Margin % | 23% | 20.82% | 20.64% | 12.55% | 26.2% | 25.54% |
| Operating Income Growth % | - | -9.9% | -0.06% | -38.77% | 110.52% | - |
| EBITDA | 2.48B | 2.27B | 2.25B | 1.59B | 2.67B | 2.87B |
| EBITDA Margin % | 30.3% | 27.93% | 27.49% | 19.28% | 32.07% | 34.71% |
| EBITDA Growth % | - | -8.28% | -0.79% | -29.38% | 67.82% | 112.13% |
| D&A (Non-Cash Add-back) | 597M | 578M | 561M | 555M | 489M | 758M |
| EBIT | 1.88B | 1.69B | 1.67B | 972M | 2.06B | 2B |
| Net Interest Income | 0 | 0 | 0 | -367M | -347M | -305M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 367M | 347M | 305M |
| Other Income/Expense | 3M | -1M | -25M | -431M | -468M | -419M |
| Pretax Income | 1.88B▲ 0% | 1.69B▼ 10.1% | 1.67B▼ 1.5% | 605M▼ 63.7% | 1.71B▲ 183.1% | 1.69B▲ 0% |
| Pretax Margin % | 23.03% | 20.81% | 20.34% | 7.33% | 20.58% | 20.47% |
| Income Tax | 422M | 349M | 321M | 127M | 157M | 259M |
| Effective Tax Rate % | 22.42% | 20.63% | 19.26% | 20.99% | 9.17% | 15.32% |
| Net Income | 1.46B▲ 0% | 1.34B▼ 8.0% | 1.35B▲ 0.2% | 479M▼ 64.4% | 1.56B▲ 224.8% | 1.43B▲ 0% |
| Net Margin % | 17.87% | 16.52% | 16.42% | 5.8% | 18.69% | 17.33% |
| Net Income Growth % | - | -8.01% | 0.22% | -64.41% | 224.84% | 277.84% |
| Net Income (Continuing) | 1.46B | 1.34B | 1.35B | 478M | 1.56B | 1.43B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 8.47▲ 0% | 7.79▼ 8.0% | 7.79▲ 0.0% | 2.76▼ 64.6% | 8.88▲ 221.7% | 8.16▲ 0% |
| EPS Growth % | - | -8.03% | 0.04% | -64.59% | 221.74% | 276.5% |
| EPS (Basic) | 8.47 | 7.79 | 7.79 | 2.77 | 8.94 | - |
| Diluted Shares Outstanding | 172.47M | 172.47M | 172.71M | 173.7M | 175.3M | 175.5M |
| Basic Shares Outstanding | 172.47M | 172.47M | 172.71M | 173.2M | 174.1M | 174.2M |
| Dividend Payout Ratio | - | - | - | - | - | - |
SOLV Balance Sheet
Solventum Corporation (SOLV) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
| Total Current Assets | 2.19B | 2.23B | 2.52B | 3.25B | 3.86B | 3.58B |
| Cash & Short-Term Investments | 91M | 61M | 194M | 762M | 878M | 561M |
| Cash Only | 91M | 61M | 194M | 762M | 878M | 561M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.18B | 1.17B | 1.31B | 1.23B | 1.03B | 1.06B |
| Days Sales Outstanding | 52.58 | 52.57 | 58.47 | 54.35 | 45.33 | 48.23 |
| Inventory | 813M | 873M | 857M | 965M | 1.07B | 1.09B |
| Days Inventory Outstanding | 91.36 | 92.76 | 89.27 | 96.21 | 100.44 | 99.31 |
| Other Current Assets | 108M | 126M | 155M | 293M | 881M | 874M |
| Total Non-Current Assets | 11.89B | 11.36B | 11.42B | 11.21B | 10.44B | 10.51B |
| Property, Plant & Equipment | 1.31B | 1.32B | 1.46B | 1.62B | 1.33B | 1.54B |
| Fixed Asset Turnover | 6.26x | 6.16x | 5.63x | 5.09x | 6.28x | 5.99x |
| Goodwill | 6.67B | 6.43B | 6.54B | 6.38B | 5.7B | 5.63B |
| Intangible Assets | 3.66B | 3.25B | 2.9B | 2.54B | 2.59B | 2.5B |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 253M | 358M | 530M | 665M | 813M | 5.38B |
| Total Assets | 14.07B▲ 0% | 13.59B▼ 3.4% | 13.94B▲ 2.6% | 14.46B▲ 3.7% | 14.29B▼ 1.1% | 14.1B▲ 0% |
| Asset Turnover | 0.58x | 0.60x | 0.59x | 0.57x | 0.58x | 0.58x |
| Asset Growth % | - | -3.42% | 2.57% | 3.69% | -1.13% | -5.92% |
| Total Current Liabilities | 1.41B | 1.31B | 1.73B | 2.7B | 3.14B | 3.35B |
| Accounts Payable | 320M | 348M | 477M | 618M | 687M | 699M |
| Days Payables Outstanding | 35.96 | 36.98 | 49.69 | 61.61 | 64.73 | 64.31 |
| Short-Term Debt | 0 | 0 | 0 | 200M | 0 | 505M |
| Deferred Revenue (Current) | 574M | 559M | 574M | 572M | 621M | 2.37B |
| Other Current Liabilities | 323M | 236M | 365M | 659M | 1.83B | 1.53B |
| Current Ratio | 1.56x | 1.70x | 1.46x | 1.20x | 1.23x | 1.23x |
| Quick Ratio | 0.98x | 1.04x | 0.96x | 0.84x | 0.89x | 0.89x |
| Cash Conversion Cycle | 107.98 | 108.36 | 98.05 | 88.94 | 81.04 | 83.22 |
| Total Non-Current Liabilities | 610M | 541M | 549M | 8.79B | 6.11B | 5.78B |
| Long-Term Debt | 0 | 0 | 8.3B | 7.81B | 5.04B | 4.58B |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 218M | 215M | 231M | 225M | 164M | 725M |
| Other Non-Current Liabilities | 392M | 326M | -7.99B | 760M | 910M | 3.46B |
| Total Liabilities | 2.02B | 1.85B | 2.28B | 11.5B | 9.24B | 9.13B |
| Total Debt | 0 | 0 | 8.3B | 8.01B | 5.04B | 5.08B |
| Net Debt | -91M | -61M | 8.11B | 7.25B | 4.16B | 4.52B |
| Debt / Equity | - | - | 0.71x | 2.71x | 1.00x | 1.00x |
| Debt / EBITDA | - | - | 3.69x | 5.03x | 1.89x | 1.77x |
| Net Debt / EBITDA | -0.04x | -0.03x | 3.60x | 4.56x | 1.56x | 1.56x |
| Interest Coverage | - | - | - | 2.65x | 5.94x | 6.55x |
| Total Equity | 12.06B▲ 0% | 11.74B▼ 2.6% | 11.67B▼ 0.6% | 2.96B▼ 74.6% | 5.05B▲ 70.6% | 4.97B▲ 0% |
| Equity Growth % | - | -2.63% | -0.65% | -74.64% | 70.63% | 206.3% |
| Book Value per Share | 69.92 | 68.08 | 67.55 | 17.04 | 28.80 | 28.31 |
| Total Shareholders' Equity | 12.06B | 11.74B | 11.67B | 2.96B | 5.05B | 4.97B |
| Common Stock | 0 | 0 | 0 | 2M | 2M | 2M |
| Retained Earnings | 0 | 0 | 0 | 242M | 1.8B | 1.81B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -200M | -497M | -337M | -1.06B | -625M | -670M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
SOLV Cash Flow Statement
Solventum Corporation (SOLV) cash flow — operating, investing & free cash flow history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|
| Cash from Operations | 2.2B | 1.68B | 1.92B | 1.19B | 369M | 369M |
| Operating CF Margin % | 26.95% | 20.65% | 23.36% | 14.36% | 4.43% | - |
| Operating CF Growth % | - | -23.75% | 14.06% | -38.12% | -68.86% | -915.77% |
| Net Income | 1.46B | 1.34B | 1.35B | 479M | 1.56B | 1.43B |
| Depreciation & Amortization | 597M | 578M | 561M | 555M | 489M | 257M |
| Stock-Based Compensation | 38M | 37M | 39M | 112M | 161M | 85M |
| Deferred Taxes | -34M | -141M | -142M | -155M | -120M | 56M |
| Other Non-Cash Items | 74M | 64M | -15M | 34M | -1.6B | -1.72B |
| Working Capital Changes | 67M | -202M | 126M | 160M | -119M | 38M |
| Change in Receivables | -1M | -32M | -129M | 276M | 78M | -4M |
| Change in Inventory | -136M | -82M | 23M | -132M | -139M | -139M |
| Change in Payables | 68M | 25M | 105M | 266M | 104M | 118M |
| Cash from Investing | -278M | -253M | -230M | -380M | 2.8B | 2.83B |
| Capital Expenditures | -277M | -251M | -290M | -380M | -379M | -354M |
| CapEx % of Revenue | 3.39% | 3.09% | 3.54% | 4.6% | 4.55% | - |
| Acquisitions | 0 | 0 | 60M | 0 | -696M | 3.87B |
| Investments | - | - | - | - | - | - |
| Other Investing | -1M | -2M | 0 | 0 | 3.87B | -683M |
| Cash from Financing | -1.96B | -1.46B | -1.55B | -240M | -3.06B | -2.97B |
| Debt Issued (Net) | 0 | 0 | 0 | 8B | -3.07B | -2.97B |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -67M |
| Other Financing | -1.96B | -1.46B | -1.55B | -8.24B | 13M | 2M |
| Net Change in Cash | -33M▲ 0% | -30M▲ 9.1% | 133M▲ 543.3% | 568M▲ 327.1% | 116M▼ 79.6% | 27M▲ 0% |
| Free Cash Flow | 1.93B▲ 0% | 1.43B▼ 25.8% | 1.63B▲ 13.8% | 805M▼ 50.5% | -10M▼ 101.2% | -203M▲ 0% |
| FCF Margin % | 23.56% | 17.56% | 19.82% | 9.75% | -0.12% | -2.46% |
| FCF Growth % | - | -25.82% | 13.8% | -50.46% | -101.24% | -152.73% |
| FCF per Share | 11.16 | 8.28 | 9.41 | 4.63 | -0.06 | -0.06 |
| FCF Conversion (FCF/Net Income) | 1.51x | 1.25x | 1.42x | 2.47x | 0.24x | -0.14x |
| Interest Paid | 0 | 0 | 0 | 287M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 244M | 0 | 0 |
SOLV Key Ratios
Solventum Corporation (SOLV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Return on Equity (ROE) | 11.29% | 11.5% | 6.55% | 38.86% | 30.71% |
| Return on Invested Capital (ROIC) | 10.74% | 8.07% | 5.18% | 16.85% | 16.85% |
| Gross Margin | 57.75% | 57.25% | 55.65% | 53.47% | 53.67% |
| Net Margin | 16.52% | 16.42% | 5.8% | 18.69% | 17.33% |
| Debt / Equity | - | 0.71x | 2.71x | 1.00x | 1.00x |
| Interest Coverage | - | - | 2.65x | 5.94x | 6.55x |
| FCF Conversion | 1.25x | 1.42x | 2.47x | 0.24x | -0.14x |
| Revenue Growth | -0.5% | 0.82% | 0.7% | 0.86% | -0.55% |
SOLV SEC Filings & Documents
Solventum Corporation (SOLV) SEC filings — annual & quarterly reports (10-K, 10-Q)
SOLV Frequently Asked Questions
Solventum Corporation (SOLV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Solventum Corporation (SOLV) reported $8.26B in revenue for fiscal year 2025. This represents a 1% increase from $8.17B in 2021.
Solventum Corporation (SOLV) grew revenue by 0.9% over the past year. Growth has been modest.
Yes, Solventum Corporation (SOLV) is profitable, generating $1.43B in net income for fiscal year 2025 (18.7% net margin).
Dividend & Returns
Solventum Corporation (SOLV) has a return on equity (ROE) of 38.9%. This is excellent, indicating efficient use of shareholder capital.
Solventum Corporation (SOLV) had negative free cash flow of $203.0M in fiscal year 2025, likely due to heavy capital investments.
Explore More SOLV
Solventum Corporation (SOLV) financial analysis — history, returns, DCA and operating performance tools
Full SOLV Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates